| Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study M Cavo, P Tosi, E Zamagni, C Cellini, P Tacchetti, F Patriarca, ... Journal of clinical oncology 25 (17), 2434-2441, 2007 | 479 | 2007 |
| Behavioral syndromes in Alzheimer’s disease: description and correlates GB Frisoni, L Rozzini, A Gozzetti, G Binetti, O Zanetti, A Bianchetti, ... Dementia and geriatric cognitive disorders 10 (2), 130-138, 1999 | 341 | 1999 |
| Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre … M Bocchia, S Gentili, E Abruzzese, A Fanelli, F Iuliano, A Tabilio, ... The Lancet 365 (9460), 657-662, 2005 | 336 | 2005 |
| Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia MR Grever, O Abdel-Wahab, LA Andritsos, V Banerji, J Barrientos, ... Blood, The Journal of the American Society of Hematology 129 (5), 553-560, 2017 | 258 | 2017 |
| Fluorescence in situ hybridization: uses and limitations A Gozzetti, MM Le Beau Seminars in hematology 37 (4), 320-333, 2000 | 226 | 2000 |
| Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma G Martinelli, C Terragna, E Zamagni, S Ronconi, P Tosi, RM Lemoli, ... Journal of Clinical Oncology 18 (11), 2273-2281, 2000 | 215 | 2000 |
| The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors D Rossi, E Sozzi, A Puma, L De Paoli, S Rasi, V Spina, A Gozzetti, ... British journal of haematology 146 (1), 64-75, 2009 | 188 | 2009 |
| Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set A Chari, MK Samur, J Martinez-Lopez, G Cook, N Biran, K Yong, ... Blood, The Journal of the American Society of Hematology 136 (26), 3033-3040, 2020 | 185 | 2020 |
| International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM) MV Mateos, S Kumar, MA Dimopoulos, V González-Calle, E Kastritis, ... Blood cancer journal 10 (10), 102, 2020 | 167 | 2020 |
| Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis S Luatti, F Castagnetti, G Marzocchi, C Baldazzi, G Gugliotta, I Iacobucci, ... Blood, The Journal of the American Society of Hematology 120 (4), 761-767, 2012 | 145 | 2012 |
| 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia M Dal Bo, FM Rossi, D Rossi, C Deambrogi, F Bertoni, I Del Giudice, ... Genes, Chromosomes and Cancer 50 (8), 633-643, 2011 | 139 | 2011 |
| Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay A Cerase, A Tarantino, A Gozzetti, CF Muccio, P Gennari, L Monti, ... Neuroradiology 50, 665-674, 2008 | 135 | 2008 |
| Efficacy of carfilzomib lenalidomide dexamethasone (KRd) with or without transplantation in newly diagnosed myeloma according to risk status: Results from the FORTE trial. F Gay, C Cerrato, MT Petrucci, R Zambello, B Gamberi, S Ballanti, ... Journal of Clinical Oncology 37 (15_suppl), 8002-8002, 2019 | 128 | 2019 |
| Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients A Gozzetti, A Cerase, F Lotti, D Rossi, A Palumbo, MT Petrucci, ... Cancer 118 (6), 1574-1584, 2012 | 127 | 2012 |
| Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis F Cavazzini, JA Hernandez, A Gozzetti, A Russo Rossi, C De Angeli, ... British journal of haematology 142 (4), 529-537, 2008 | 125 | 2008 |
| Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma PL Zinzani, F Lauria, D Rondelli, D Benfenati, D Raspadori, M Bocchia, ... Annals of oncology 4 (7), 575-578, 1993 | 123 | 1993 |
| Central nervous system involvement by multiple myeloma: a multi‐institutional retrospective study of 172 patients in daily clinical practice A Jurczyszyn, N Grzasko, A Gozzetti, J Czepiel, A Cerase, V Hungria, ... American journal of hematology 91 (6), 575-580, 2016 | 115 | 2016 |
| Primary plasma cell leukemia: a retrospective multicenter study of 73 patients L Pagano, CG Valentini, V De Stefano, A Venditti, G Visani, MT Petrucci, ... Annals of oncology 22 (7), 1628-1635, 2011 | 112 | 2011 |
| Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic … N Testoni, G Marzocchi, S Luatti, M Amabile, C Baldazzi, M Stacchini, ... Blood, The Journal of the American Society of Hematology 114 (24), 4939-4943, 2009 | 97 | 2009 |
| Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission M Bocchia, A Sicuranza, E Abruzzese, A Iurlo, S Sirianni, A Gozzini, ... Frontiers in Oncology 8, 194, 2018 | 96 | 2018 |
Michele CavoProfessor of HematologyZweryfikowany adres z unibo.it
